nodes	percent_of_prediction	percent_of_DWPC	metapath
Mycophenolate mofetil—psoriasis—skin cancer	0.546	1	CtDrD
Mycophenolate mofetil—ABCG2—Vismodegib—skin cancer	0.0425	0.127	CbGbCtD
Mycophenolate mofetil—ABCG2—Vemurafenib—skin cancer	0.0336	0.1	CbGbCtD
Mycophenolate mofetil—ALB—Vismodegib—skin cancer	0.0293	0.0873	CbGbCtD
Mycophenolate mofetil—SLCO1B3—Docetaxel—skin cancer	0.0249	0.0743	CbGbCtD
Mycophenolate mofetil—ALB—Vemurafenib—skin cancer	0.0232	0.069	CbGbCtD
Mycophenolate mofetil—CYP2C8—Vismodegib—skin cancer	0.0226	0.0675	CbGbCtD
Mycophenolate mofetil—ABCG2—Dactinomycin—skin cancer	0.0223	0.0665	CbGbCtD
Mycophenolate mofetil—ABCB1—Vismodegib—skin cancer	0.0153	0.0457	CbGbCtD
Mycophenolate mofetil—ABCG2—Fluorouracil—skin cancer	0.0151	0.045	CbGbCtD
Mycophenolate mofetil—CYP3A4—Temozolomide—skin cancer	0.0132	0.0395	CbGbCtD
Mycophenolate mofetil—CYP3A4—Imiquimod—skin cancer	0.0132	0.0395	CbGbCtD
Mycophenolate mofetil—ABCC2—Docetaxel—skin cancer	0.0128	0.038	CbGbCtD
Mycophenolate mofetil—ABCG2—Docetaxel—skin cancer	0.0115	0.0344	CbGbCtD
Mycophenolate mofetil—ALB—Fluorouracil—skin cancer	0.0104	0.031	CbGbCtD
Mycophenolate mofetil—CYP3A4—Vismodegib—skin cancer	0.00918	0.0274	CbGbCtD
Mycophenolate mofetil—ABCB1—Dactinomycin—skin cancer	0.00805	0.024	CbGbCtD
Mycophenolate mofetil—CYP2C8—Fluorouracil—skin cancer	0.00804	0.024	CbGbCtD
Mycophenolate mofetil—CYP3A4—Vemurafenib—skin cancer	0.00726	0.0216	CbGbCtD
Mycophenolate mofetil—CYP3A5—Docetaxel—skin cancer	0.00639	0.019	CbGbCtD
Mycophenolate mofetil—ABCB1—Docetaxel—skin cancer	0.00416	0.0124	CbGbCtD
Mycophenolate mofetil—CYP3A4—Docetaxel—skin cancer	0.00249	0.00742	CbGbCtD
Mycophenolate mofetil—IMPDH2—hair follicle—skin cancer	0.00113	0.0827	CbGeAlD
Mycophenolate mofetil—IMPDH2—nipple—skin cancer	0.000765	0.056	CbGeAlD
Mycophenolate mofetil—IMPDH2—neck—skin cancer	0.000757	0.0555	CbGeAlD
Mycophenolate mofetil—CES2—nipple—skin cancer	0.000695	0.0509	CbGeAlD
Mycophenolate mofetil—UGT1A8—head—skin cancer	0.000568	0.0416	CbGeAlD
Mycophenolate mofetil—CES1—neck—skin cancer	0.000567	0.0415	CbGeAlD
Mycophenolate mofetil—IMPDH2—skin of body—skin cancer	0.00049	0.0359	CbGeAlD
Mycophenolate mofetil—IMPDH2—mammalian vulva—skin cancer	0.000447	0.0327	CbGeAlD
Mycophenolate mofetil—CES2—skin of body—skin cancer	0.000445	0.0326	CbGeAlD
Mycophenolate mofetil—IMPDH1—mammalian vulva—skin cancer	0.000444	0.0325	CbGeAlD
Mycophenolate mofetil—CES2—mammalian vulva—skin cancer	0.000406	0.0298	CbGeAlD
Mycophenolate mofetil—CES1—connective tissue—skin cancer	0.000406	0.0297	CbGeAlD
Mycophenolate mofetil—IMPDH2—lymphoid tissue—skin cancer	0.000397	0.0291	CbGeAlD
Mycophenolate mofetil—IMPDH1—lymphoid tissue—skin cancer	0.000394	0.0289	CbGeAlD
Mycophenolate mofetil—IMPDH2—female reproductive system—skin cancer	0.000383	0.028	CbGeAlD
Mycophenolate mofetil—IMPDH1—female reproductive system—skin cancer	0.00038	0.0279	CbGeAlD
Mycophenolate mofetil—CES2—female reproductive system—skin cancer	0.000348	0.0255	CbGeAlD
Mycophenolate mofetil—UGT2B7—female reproductive system—skin cancer	0.000348	0.0255	CbGeAlD
Mycophenolate mofetil—IMPDH2—head—skin cancer	0.00032	0.0234	CbGeAlD
Mycophenolate mofetil—IMPDH1—head—skin cancer	0.000318	0.0233	CbGeAlD
Mycophenolate mofetil—CES1—lymphoid tissue—skin cancer	0.000297	0.0218	CbGeAlD
Mycophenolate mofetil—CES2—head—skin cancer	0.000291	0.0213	CbGeAlD
Mycophenolate mofetil—CES1—female reproductive system—skin cancer	0.000286	0.021	CbGeAlD
Mycophenolate mofetil—SLCO1B1—female reproductive system—skin cancer	0.000246	0.018	CbGeAlD
Mycophenolate mofetil—CES1—head—skin cancer	0.000239	0.0175	CbGeAlD
Mycophenolate mofetil—IMPDH2—lymph node—skin cancer	0.000224	0.0164	CbGeAlD
Mycophenolate mofetil—IMPDH1—lymph node—skin cancer	0.000222	0.0163	CbGeAlD
Mycophenolate mofetil—CES2—lymph node—skin cancer	0.000203	0.0149	CbGeAlD
Mycophenolate mofetil—ABCC2—female reproductive system—skin cancer	0.000187	0.0137	CbGeAlD
Mycophenolate mofetil—ABCB1—blood vessel—skin cancer	0.000186	0.0136	CbGeAlD
Mycophenolate mofetil—CES1—lymph node—skin cancer	0.000168	0.0123	CbGeAlD
Mycophenolate mofetil—ABCG2—mammalian vulva—skin cancer	0.000159	0.0116	CbGeAlD
Mycophenolate mofetil—CYP2C8—female reproductive system—skin cancer	0.00014	0.0102	CbGeAlD
Mycophenolate mofetil—ALB—lymph node—skin cancer	0.000116	0.00853	CbGeAlD
Mycophenolate mofetil—ABCC2—lymph node—skin cancer	0.000109	0.00799	CbGeAlD
Mycophenolate mofetil—CYP3A4—female reproductive system—skin cancer	9.48e-05	0.00694	CbGeAlD
Mycophenolate mofetil—ABCB1—epithelium—skin cancer	9.03e-05	0.00662	CbGeAlD
Mycophenolate mofetil—Liver function test abnormal—Docetaxel—skin cancer	8.38e-05	0.000799	CcSEcCtD
Mycophenolate mofetil—Vomiting—Vemurafenib—skin cancer	8.35e-05	0.000796	CcSEcCtD
Mycophenolate mofetil—Alopecia—Temozolomide—skin cancer	8.34e-05	0.000796	CcSEcCtD
Mycophenolate mofetil—Chest pain—Bleomycin—skin cancer	8.3e-05	0.000791	CcSEcCtD
Mycophenolate mofetil—Myalgia—Bleomycin—skin cancer	8.3e-05	0.000791	CcSEcCtD
Mycophenolate mofetil—Orthostatic hypotension—Docetaxel—skin cancer	8.29e-05	0.000791	CcSEcCtD
Mycophenolate mofetil—Rash—Vemurafenib—skin cancer	8.28e-05	0.000789	CcSEcCtD
Mycophenolate mofetil—Mental disorder—Temozolomide—skin cancer	8.27e-05	0.000789	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Vemurafenib—skin cancer	8.27e-05	0.000789	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Imiquimod—skin cancer	8.25e-05	0.000787	CcSEcCtD
Mycophenolate mofetil—Headache—Vemurafenib—skin cancer	8.22e-05	0.000784	CcSEcCtD
Mycophenolate mofetil—Malnutrition—Temozolomide—skin cancer	8.22e-05	0.000784	CcSEcCtD
Mycophenolate mofetil—Discomfort—Bleomycin—skin cancer	8.2e-05	0.000782	CcSEcCtD
Mycophenolate mofetil—Malaise—Dactinomycin—skin cancer	8.19e-05	0.000782	CcSEcCtD
Mycophenolate mofetil—Aspartate aminotransferase increased—Docetaxel—skin cancer	8.17e-05	0.00078	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Dactinomycin—skin cancer	8.13e-05	0.000776	CcSEcCtD
Mycophenolate mofetil—Dysgeusia—Temozolomide—skin cancer	8.05e-05	0.000768	CcSEcCtD
Mycophenolate mofetil—Asthenia—Imiquimod—skin cancer	8.03e-05	0.000766	CcSEcCtD
Mycophenolate mofetil—Confusional state—Bleomycin—skin cancer	8.02e-05	0.000765	CcSEcCtD
Mycophenolate mofetil—Alanine aminotransferase increased—Docetaxel—skin cancer	8e-05	0.000764	CcSEcCtD
Mycophenolate mofetil—ABCG2—lymph node—skin cancer	7.96e-05	0.00583	CbGeAlD
Mycophenolate mofetil—Anaphylactic shock—Bleomycin—skin cancer	7.95e-05	0.000759	CcSEcCtD
Mycophenolate mofetil—Oedema—Bleomycin—skin cancer	7.95e-05	0.000759	CcSEcCtD
Mycophenolate mofetil—Back pain—Temozolomide—skin cancer	7.95e-05	0.000758	CcSEcCtD
Mycophenolate mofetil—Pruritus—Imiquimod—skin cancer	7.92e-05	0.000755	CcSEcCtD
Mycophenolate mofetil—Infection—Bleomycin—skin cancer	7.9e-05	0.000754	CcSEcCtD
Mycophenolate mofetil—Dysphagia—Docetaxel—skin cancer	7.84e-05	0.000748	CcSEcCtD
Mycophenolate mofetil—ABCB1—mammalian vulva—skin cancer	7.83e-05	0.00574	CbGeAlD
Mycophenolate mofetil—Nausea—Vemurafenib—skin cancer	7.8e-05	0.000744	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Bleomycin—skin cancer	7.79e-05	0.000743	CcSEcCtD
Mycophenolate mofetil—Arrhythmia—Fluorouracil—skin cancer	7.77e-05	0.000741	CcSEcCtD
Mycophenolate mofetil—Myalgia—Dactinomycin—skin cancer	7.74e-05	0.000738	CcSEcCtD
Mycophenolate mofetil—Tremor—Temozolomide—skin cancer	7.7e-05	0.000735	CcSEcCtD
Mycophenolate mofetil—Alopecia—Fluorouracil—skin cancer	7.69e-05	0.000733	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Imiquimod—skin cancer	7.66e-05	0.000731	CcSEcCtD
Mycophenolate mofetil—Discomfort—Dactinomycin—skin cancer	7.64e-05	0.000729	CcSEcCtD
Mycophenolate mofetil—Angina pectoris—Docetaxel—skin cancer	7.64e-05	0.000729	CcSEcCtD
Mycophenolate mofetil—Ill-defined disorder—Temozolomide—skin cancer	7.63e-05	0.000727	CcSEcCtD
Mycophenolate mofetil—Anaemia—Temozolomide—skin cancer	7.6e-05	0.000725	CcSEcCtD
Mycophenolate mofetil—Anorexia—Bleomycin—skin cancer	7.58e-05	0.000723	CcSEcCtD
Mycophenolate mofetil—Agitation—Temozolomide—skin cancer	7.55e-05	0.00072	CcSEcCtD
Mycophenolate mofetil—Angioedema—Temozolomide—skin cancer	7.51e-05	0.000716	CcSEcCtD
Mycophenolate mofetil—Pancytopenia—Docetaxel—skin cancer	7.45e-05	0.000711	CcSEcCtD
Mycophenolate mofetil—Hypotension—Bleomycin—skin cancer	7.43e-05	0.000709	CcSEcCtD
Mycophenolate mofetil—Oedema—Dactinomycin—skin cancer	7.42e-05	0.000707	CcSEcCtD
Mycophenolate mofetil—Malaise—Temozolomide—skin cancer	7.41e-05	0.000707	CcSEcCtD
Mycophenolate mofetil—Dizziness—Imiquimod—skin cancer	7.4e-05	0.000706	CcSEcCtD
Mycophenolate mofetil—Vertigo—Temozolomide—skin cancer	7.38e-05	0.000704	CcSEcCtD
Mycophenolate mofetil—Infection—Dactinomycin—skin cancer	7.37e-05	0.000703	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Temozolomide—skin cancer	7.36e-05	0.000702	CcSEcCtD
Mycophenolate mofetil—Neutropenia—Docetaxel—skin cancer	7.34e-05	0.0007	CcSEcCtD
Mycophenolate mofetil—Palpitations—Temozolomide—skin cancer	7.26e-05	0.000693	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Dactinomycin—skin cancer	7.26e-05	0.000693	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Bleomycin—skin cancer	7.25e-05	0.000691	CcSEcCtD
Mycophenolate mofetil—Cough—Temozolomide—skin cancer	7.17e-05	0.000684	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Bleomycin—skin cancer	7.14e-05	0.000681	CcSEcCtD
Mycophenolate mofetil—Weight increased—Docetaxel—skin cancer	7.14e-05	0.000681	CcSEcCtD
Mycophenolate mofetil—Convulsion—Temozolomide—skin cancer	7.12e-05	0.000679	CcSEcCtD
Mycophenolate mofetil—Vomiting—Imiquimod—skin cancer	7.12e-05	0.000679	CcSEcCtD
Mycophenolate mofetil—Weight decreased—Docetaxel—skin cancer	7.1e-05	0.000677	CcSEcCtD
Mycophenolate mofetil—Hypertension—Temozolomide—skin cancer	7.1e-05	0.000677	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Bleomycin—skin cancer	7.09e-05	0.000676	CcSEcCtD
Mycophenolate mofetil—Anorexia—Dactinomycin—skin cancer	7.07e-05	0.000674	CcSEcCtD
Mycophenolate mofetil—Rash—Imiquimod—skin cancer	7.06e-05	0.000673	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Imiquimod—skin cancer	7.05e-05	0.000673	CcSEcCtD
Mycophenolate mofetil—Pneumonia—Docetaxel—skin cancer	7.04e-05	0.000671	CcSEcCtD
Mycophenolate mofetil—Headache—Imiquimod—skin cancer	7.01e-05	0.000669	CcSEcCtD
Mycophenolate mofetil—Anaemia—Fluorouracil—skin cancer	7e-05	0.000668	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Temozolomide—skin cancer	7e-05	0.000667	CcSEcCtD
Mycophenolate mofetil—Myalgia—Temozolomide—skin cancer	7e-05	0.000667	CcSEcCtD
Mycophenolate mofetil—Infestation NOS—Docetaxel—skin cancer	6.99e-05	0.000667	CcSEcCtD
Mycophenolate mofetil—Infestation—Docetaxel—skin cancer	6.99e-05	0.000667	CcSEcCtD
Mycophenolate mofetil—Anxiety—Temozolomide—skin cancer	6.97e-05	0.000665	CcSEcCtD
Mycophenolate mofetil—ABCB1—lymphoid tissue—skin cancer	6.95e-05	0.0051	CbGeAlD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	6.95e-05	0.000663	CcSEcCtD
Mycophenolate mofetil—Discomfort—Temozolomide—skin cancer	6.91e-05	0.000659	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Bleomycin—skin cancer	6.91e-05	0.000659	CcSEcCtD
Mycophenolate mofetil—Acute coronary syndrome—Docetaxel—skin cancer	6.89e-05	0.000658	CcSEcCtD
Mycophenolate mofetil—Renal failure—Docetaxel—skin cancer	6.88e-05	0.000656	CcSEcCtD
Mycophenolate mofetil—Myocardial infarction—Docetaxel—skin cancer	6.86e-05	0.000654	CcSEcCtD
Mycophenolate mofetil—Neuropathy peripheral—Docetaxel—skin cancer	6.86e-05	0.000654	CcSEcCtD
Mycophenolate mofetil—Dry mouth—Temozolomide—skin cancer	6.84e-05	0.000653	CcSEcCtD
Mycophenolate mofetil—Stomatitis—Docetaxel—skin cancer	6.82e-05	0.00065	CcSEcCtD
Mycophenolate mofetil—Jaundice—Docetaxel—skin cancer	6.82e-05	0.00065	CcSEcCtD
Mycophenolate mofetil—Pain—Bleomycin—skin cancer	6.8e-05	0.000649	CcSEcCtD
Mycophenolate mofetil—Conjunctivitis—Docetaxel—skin cancer	6.8e-05	0.000648	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Fluorouracil—skin cancer	6.78e-05	0.000647	CcSEcCtD
Mycophenolate mofetil—Confusional state—Temozolomide—skin cancer	6.76e-05	0.000645	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Dactinomycin—skin cancer	6.76e-05	0.000645	CcSEcCtD
Mycophenolate mofetil—Oedema—Temozolomide—skin cancer	6.71e-05	0.00064	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Temozolomide—skin cancer	6.71e-05	0.00064	CcSEcCtD
Mycophenolate mofetil—ABCB1—female reproductive system—skin cancer	6.71e-05	0.00491	CbGeAlD
Mycophenolate mofetil—Infection—Temozolomide—skin cancer	6.66e-05	0.000636	CcSEcCtD
Mycophenolate mofetil—Nausea—Imiquimod—skin cancer	6.65e-05	0.000634	CcSEcCtD
Mycophenolate mofetil—Hepatobiliary disease—Docetaxel—skin cancer	6.61e-05	0.000631	CcSEcCtD
Mycophenolate mofetil—Epistaxis—Docetaxel—skin cancer	6.6e-05	0.000629	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Temozolomide—skin cancer	6.58e-05	0.000627	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Temozolomide—skin cancer	6.57e-05	0.000626	CcSEcCtD
Mycophenolate mofetil—Convulsion—Fluorouracil—skin cancer	6.56e-05	0.000626	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Bleomycin—skin cancer	6.55e-05	0.000625	CcSEcCtD
Mycophenolate mofetil—Agranulocytosis—Docetaxel—skin cancer	6.53e-05	0.000623	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Temozolomide—skin cancer	6.52e-05	0.000621	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Temozolomide—skin cancer	6.48e-05	0.000619	CcSEcCtD
Mycophenolate mofetil—Chest pain—Fluorouracil—skin cancer	6.45e-05	0.000615	CcSEcCtD
Mycophenolate mofetil—Myalgia—Fluorouracil—skin cancer	6.45e-05	0.000615	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Dactinomycin—skin cancer	6.45e-05	0.000615	CcSEcCtD
Mycophenolate mofetil—Anorexia—Temozolomide—skin cancer	6.39e-05	0.00061	CcSEcCtD
Mycophenolate mofetil—Discomfort—Fluorouracil—skin cancer	6.37e-05	0.000608	CcSEcCtD
Mycophenolate mofetil—Pain—Dactinomycin—skin cancer	6.34e-05	0.000605	CcSEcCtD
Mycophenolate mofetil—Urticaria—Bleomycin—skin cancer	6.32e-05	0.000603	CcSEcCtD
Mycophenolate mofetil—Haemoglobin—Docetaxel—skin cancer	6.31e-05	0.000602	CcSEcCtD
Mycophenolate mofetil—Rhinitis—Docetaxel—skin cancer	6.29e-05	0.0006	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Bleomycin—skin cancer	6.29e-05	0.0006	CcSEcCtD
Mycophenolate mofetil—Hepatitis—Docetaxel—skin cancer	6.28e-05	0.000599	CcSEcCtD
Mycophenolate mofetil—Haemorrhage—Docetaxel—skin cancer	6.28e-05	0.000599	CcSEcCtD
Mycophenolate mofetil—Hypoaesthesia—Docetaxel—skin cancer	6.25e-05	0.000596	CcSEcCtD
Mycophenolate mofetil—Confusional state—Fluorouracil—skin cancer	6.23e-05	0.000594	CcSEcCtD
Mycophenolate mofetil—Pharyngitis—Docetaxel—skin cancer	6.23e-05	0.000594	CcSEcCtD
Mycophenolate mofetil—Urinary tract disorder—Docetaxel—skin cancer	6.2e-05	0.000591	CcSEcCtD
Mycophenolate mofetil—Oedema peripheral—Docetaxel—skin cancer	6.19e-05	0.00059	CcSEcCtD
Mycophenolate mofetil—Oedema—Fluorouracil—skin cancer	6.18e-05	0.00059	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Fluorouracil—skin cancer	6.18e-05	0.00059	CcSEcCtD
Mycophenolate mofetil—Connective tissue disorder—Docetaxel—skin cancer	6.17e-05	0.000589	CcSEcCtD
Mycophenolate mofetil—Urethral disorder—Docetaxel—skin cancer	6.15e-05	0.000587	CcSEcCtD
Mycophenolate mofetil—Infection—Fluorouracil—skin cancer	6.14e-05	0.000586	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Dactinomycin—skin cancer	6.11e-05	0.000583	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Temozolomide—skin cancer	6.11e-05	0.000583	CcSEcCtD
Mycophenolate mofetil—Insomnia—Temozolomide—skin cancer	6.07e-05	0.000579	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Dactinomycin—skin cancer	6.06e-05	0.000578	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Fluorouracil—skin cancer	6.06e-05	0.000578	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Fluorouracil—skin cancer	6.05e-05	0.000577	CcSEcCtD
Mycophenolate mofetil—Visual impairment—Docetaxel—skin cancer	6.05e-05	0.000577	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Fluorouracil—skin cancer	6.03e-05	0.000575	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Temozolomide—skin cancer	6.02e-05	0.000575	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Temozolomide—skin cancer	5.98e-05	0.00057	CcSEcCtD
Mycophenolate mofetil—Somnolence—Temozolomide—skin cancer	5.96e-05	0.000569	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Temozolomide—skin cancer	5.9e-05	0.000563	CcSEcCtD
Mycophenolate mofetil—Anorexia—Fluorouracil—skin cancer	5.89e-05	0.000562	CcSEcCtD
Mycophenolate mofetil—Eye disorder—Docetaxel—skin cancer	5.87e-05	0.00056	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Dactinomycin—skin cancer	5.86e-05	0.000559	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Dactinomycin—skin cancer	5.86e-05	0.000559	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Bleomycin—skin cancer	5.86e-05	0.000559	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Temozolomide—skin cancer	5.83e-05	0.000556	CcSEcCtD
Mycophenolate mofetil—Cardiac disorder—Docetaxel—skin cancer	5.83e-05	0.000556	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Temozolomide—skin cancer	5.79e-05	0.000552	CcSEcCtD
Mycophenolate mofetil—Hypotension—Fluorouracil—skin cancer	5.78e-05	0.000551	CcSEcCtD
Mycophenolate mofetil—Pain—Temozolomide—skin cancer	5.74e-05	0.000547	CcSEcCtD
Mycophenolate mofetil—Constipation—Temozolomide—skin cancer	5.74e-05	0.000547	CcSEcCtD
Mycophenolate mofetil—Asthenia—Bleomycin—skin cancer	5.71e-05	0.000544	CcSEcCtD
Mycophenolate mofetil—Angiopathy—Docetaxel—skin cancer	5.7e-05	0.000543	CcSEcCtD
Mycophenolate mofetil—Mediastinal disorder—Docetaxel—skin cancer	5.66e-05	0.00054	CcSEcCtD
Mycophenolate mofetil—Chills—Docetaxel—skin cancer	5.63e-05	0.000537	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Fluorouracil—skin cancer	5.63e-05	0.000537	CcSEcCtD
Mycophenolate mofetil—Pruritus—Bleomycin—skin cancer	5.63e-05	0.000537	CcSEcCtD
Mycophenolate mofetil—Arrhythmia—Docetaxel—skin cancer	5.61e-05	0.000535	CcSEcCtD
Mycophenolate mofetil—ABCB1—head—skin cancer	5.6e-05	0.00411	CbGeAlD
Mycophenolate mofetil—Insomnia—Fluorouracil—skin cancer	5.59e-05	0.000533	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Fluorouracil—skin cancer	5.55e-05	0.000529	CcSEcCtD
Mycophenolate mofetil—Alopecia—Docetaxel—skin cancer	5.55e-05	0.000529	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Temozolomide—skin cancer	5.53e-05	0.000527	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Fluorouracil—skin cancer	5.51e-05	0.000526	CcSEcCtD
Mycophenolate mofetil—Mental disorder—Docetaxel—skin cancer	5.5e-05	0.000525	CcSEcCtD
Mycophenolate mofetil—Somnolence—Fluorouracil—skin cancer	5.49e-05	0.000524	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Temozolomide—skin cancer	5.49e-05	0.000523	CcSEcCtD
Mycophenolate mofetil—Malnutrition—Docetaxel—skin cancer	5.47e-05	0.000521	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Dactinomycin—skin cancer	5.46e-05	0.000521	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Fluorouracil—skin cancer	5.44e-05	0.000519	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Fluorouracil—skin cancer	5.37e-05	0.000512	CcSEcCtD
Mycophenolate mofetil—Dysgeusia—Docetaxel—skin cancer	5.35e-05	0.000511	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Fluorouracil—skin cancer	5.34e-05	0.000509	CcSEcCtD
Mycophenolate mofetil—Urticaria—Temozolomide—skin cancer	5.33e-05	0.000508	CcSEcCtD
Mycophenolate mofetil—Asthenia—Dactinomycin—skin cancer	5.32e-05	0.000508	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Temozolomide—skin cancer	5.3e-05	0.000506	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Temozolomide—skin cancer	5.3e-05	0.000506	CcSEcCtD
Mycophenolate mofetil—Back pain—Docetaxel—skin cancer	5.29e-05	0.000504	CcSEcCtD
Mycophenolate mofetil—Pain—Fluorouracil—skin cancer	5.29e-05	0.000504	CcSEcCtD
Mycophenolate mofetil—Muscle spasms—Docetaxel—skin cancer	5.26e-05	0.000501	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Fluorouracil—skin cancer	5.09e-05	0.000486	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Dactinomycin—skin cancer	5.07e-05	0.000484	CcSEcCtD
Mycophenolate mofetil—Vomiting—Bleomycin—skin cancer	5.06e-05	0.000482	CcSEcCtD
Mycophenolate mofetil—Anaemia—Docetaxel—skin cancer	5.05e-05	0.000482	CcSEcCtD
Mycophenolate mofetil—Rash—Bleomycin—skin cancer	5.01e-05	0.000478	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Bleomycin—skin cancer	5.01e-05	0.000478	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Temozolomide—skin cancer	4.94e-05	0.000471	CcSEcCtD
Mycophenolate mofetil—Urticaria—Fluorouracil—skin cancer	4.91e-05	0.000468	CcSEcCtD
Mycophenolate mofetil—Syncope—Docetaxel—skin cancer	4.9e-05	0.000468	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Docetaxel—skin cancer	4.89e-05	0.000467	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Fluorouracil—skin cancer	4.89e-05	0.000466	CcSEcCtD
Mycophenolate mofetil—Palpitations—Docetaxel—skin cancer	4.83e-05	0.000461	CcSEcCtD
Mycophenolate mofetil—Asthenia—Temozolomide—skin cancer	4.81e-05	0.000459	CcSEcCtD
Mycophenolate mofetil—Loss of consciousness—Docetaxel—skin cancer	4.8e-05	0.000458	CcSEcCtD
Mycophenolate mofetil—Cough—Docetaxel—skin cancer	4.77e-05	0.000455	CcSEcCtD
Mycophenolate mofetil—Pruritus—Temozolomide—skin cancer	4.75e-05	0.000453	CcSEcCtD
Mycophenolate mofetil—Convulsion—Docetaxel—skin cancer	4.74e-05	0.000452	CcSEcCtD
Mycophenolate mofetil—Nausea—Bleomycin—skin cancer	4.72e-05	0.000451	CcSEcCtD
Mycophenolate mofetil—Hypertension—Docetaxel—skin cancer	4.72e-05	0.00045	CcSEcCtD
Mycophenolate mofetil—Vomiting—Dactinomycin—skin cancer	4.72e-05	0.00045	CcSEcCtD
Mycophenolate mofetil—Rash—Dactinomycin—skin cancer	4.68e-05	0.000446	CcSEcCtD
Mycophenolate mofetil—Chest pain—Docetaxel—skin cancer	4.65e-05	0.000444	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Docetaxel—skin cancer	4.65e-05	0.000444	CcSEcCtD
Mycophenolate mofetil—Myalgia—Docetaxel—skin cancer	4.65e-05	0.000444	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	4.62e-05	0.000441	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Temozolomide—skin cancer	4.59e-05	0.000438	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Fluorouracil—skin cancer	4.55e-05	0.000434	CcSEcCtD
Mycophenolate mofetil—Dry mouth—Docetaxel—skin cancer	4.55e-05	0.000434	CcSEcCtD
Mycophenolate mofetil—Confusional state—Docetaxel—skin cancer	4.5e-05	0.000429	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Docetaxel—skin cancer	4.46e-05	0.000426	CcSEcCtD
Mycophenolate mofetil—Oedema—Docetaxel—skin cancer	4.46e-05	0.000426	CcSEcCtD
Mycophenolate mofetil—Dizziness—Temozolomide—skin cancer	4.44e-05	0.000423	CcSEcCtD
Mycophenolate mofetil—Infection—Docetaxel—skin cancer	4.43e-05	0.000423	CcSEcCtD
Mycophenolate mofetil—Nausea—Dactinomycin—skin cancer	4.41e-05	0.00042	CcSEcCtD
Mycophenolate mofetil—Shock—Docetaxel—skin cancer	4.39e-05	0.000419	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Docetaxel—skin cancer	4.37e-05	0.000417	CcSEcCtD
Mycophenolate mofetil—Pruritus—Fluorouracil—skin cancer	4.37e-05	0.000417	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Docetaxel—skin cancer	4.37e-05	0.000417	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Docetaxel—skin cancer	4.35e-05	0.000415	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Docetaxel—skin cancer	4.33e-05	0.000413	CcSEcCtD
Mycophenolate mofetil—Vomiting—Temozolomide—skin cancer	4.27e-05	0.000407	CcSEcCtD
Mycophenolate mofetil—Anorexia—Docetaxel—skin cancer	4.25e-05	0.000406	CcSEcCtD
Mycophenolate mofetil—Rash—Temozolomide—skin cancer	4.23e-05	0.000403	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Fluorouracil—skin cancer	4.23e-05	0.000403	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Temozolomide—skin cancer	4.23e-05	0.000403	CcSEcCtD
Mycophenolate mofetil—Headache—Temozolomide—skin cancer	4.2e-05	0.000401	CcSEcCtD
Mycophenolate mofetil—Hypotension—Docetaxel—skin cancer	4.17e-05	0.000398	CcSEcCtD
Mycophenolate mofetil—Dizziness—Fluorouracil—skin cancer	4.09e-05	0.00039	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Docetaxel—skin cancer	4.06e-05	0.000388	CcSEcCtD
Mycophenolate mofetil—Insomnia—Docetaxel—skin cancer	4.03e-05	0.000385	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Docetaxel—skin cancer	4.01e-05	0.000382	CcSEcCtD
Mycophenolate mofetil—Nausea—Temozolomide—skin cancer	3.98e-05	0.00038	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Docetaxel—skin cancer	3.98e-05	0.000379	CcSEcCtD
Mycophenolate mofetil—Somnolence—Docetaxel—skin cancer	3.97e-05	0.000378	CcSEcCtD
Mycophenolate mofetil—Vomiting—Fluorouracil—skin cancer	3.93e-05	0.000375	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Docetaxel—skin cancer	3.93e-05	0.000375	CcSEcCtD
Mycophenolate mofetil—ABCB1—lymph node—skin cancer	3.92e-05	0.00287	CbGeAlD
Mycophenolate mofetil—Rash—Fluorouracil—skin cancer	3.9e-05	0.000372	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Fluorouracil—skin cancer	3.89e-05	0.000371	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Docetaxel—skin cancer	3.88e-05	0.00037	CcSEcCtD
Mycophenolate mofetil—Headache—Fluorouracil—skin cancer	3.87e-05	0.000369	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Docetaxel—skin cancer	3.85e-05	0.000367	CcSEcCtD
Mycophenolate mofetil—Pain—Docetaxel—skin cancer	3.81e-05	0.000364	CcSEcCtD
Mycophenolate mofetil—Constipation—Docetaxel—skin cancer	3.81e-05	0.000364	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Docetaxel—skin cancer	3.68e-05	0.000351	CcSEcCtD
Mycophenolate mofetil—Nausea—Fluorouracil—skin cancer	3.67e-05	0.00035	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Docetaxel—skin cancer	3.65e-05	0.000348	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Docetaxel—skin cancer	3.53e-05	0.000336	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Docetaxel—skin cancer	3.53e-05	0.000336	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Docetaxel—skin cancer	3.29e-05	0.000313	CcSEcCtD
Mycophenolate mofetil—Asthenia—Docetaxel—skin cancer	3.2e-05	0.000305	CcSEcCtD
Mycophenolate mofetil—Pruritus—Docetaxel—skin cancer	3.16e-05	0.000301	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Docetaxel—skin cancer	3.05e-05	0.000291	CcSEcCtD
Mycophenolate mofetil—Dizziness—Docetaxel—skin cancer	2.95e-05	0.000281	CcSEcCtD
Mycophenolate mofetil—Vomiting—Docetaxel—skin cancer	2.84e-05	0.000271	CcSEcCtD
Mycophenolate mofetil—Rash—Docetaxel—skin cancer	2.81e-05	0.000268	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Docetaxel—skin cancer	2.81e-05	0.000268	CcSEcCtD
Mycophenolate mofetil—Headache—Docetaxel—skin cancer	2.79e-05	0.000267	CcSEcCtD
Mycophenolate mofetil—Nausea—Docetaxel—skin cancer	2.65e-05	0.000253	CcSEcCtD
